GERN

Geron Corporation News Headlines

$3.59
*  
0.25
6.51%
Get GERN Alerts
*Delayed - data as of Nov. 25, 2014  -  Find a broker to begin trading GERN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
3 Healthcare Stocks Short-Sellers Are Wrong About
11/21/2014 10:27:02 AM - Motley Fool


Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog
11/19/2014 11:23:00 AM - Zacks.com


Can the Rally in Geron (GERN) Shares Continue? - Tale of the Tape
11/19/2014 8:43:22 AM - Zacks.com


Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal
11/17/2014 10:40:00 AM - TheStreet


Geron Collaborates with J&J for Imetelstat - Analyst Blog
11/14/2014 6:00:00 PM - Zacks.com


Geron's Short Squeeze Is Here
11/14/2014 3:40:00 PM - Seeking Alpha


Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
11/14/2014 3:36:00 PM - TheStreet


Health Care Sector Update for 11/14/2014: GERN,JNJ,IMUC,VASC
11/14/2014 2:06:22 PM - MT Newswires


Geron's Risk/Reward Profile Improves As Near-Term Uncertainty Ends
11/7/2014 1:06:00 PM - Seeking Alpha


Biotech Stock Roundup: Regeneron's Eylea Stumbles, Geron Up on Lifting of Clinical Hold - Analyst Blog
11/5/2014 9:46:00 AM - Zacks.com


Mid-Day Market Update: Ford Falls On October Sales Report; Geron Shares Climb
11/3/2014 1:20:18 PM - Benzinga


Mid-Morning Market Update: Markets Mixed; Publicis To Acquire Sapient For $3.7 Billion
11/3/2014 11:14:12 AM - Benzinga


Why Geron Corporation Shares Skyrocketed
11/3/2014 11:06:01 AM - Motley Fool


Geron (GERN) Stock Surges After FDA Removes Full Clinical Hold on Imetelstat Application
11/3/2014 10:28:00 AM - TheStreet


Pre-Market Most Active for Nov 3, 2014 : SAPE, ARCP, GERN, SAP, WAC, NOK, UN, FB, BABA, PBR, TVIX, AAPL
11/3/2014 8:39:51 AM - NASDAQ.com News


Betting On Big Data To Beat Aging
10/28/2014 4:31:00 PM - Seeking Alpha


Is Sarepta Therapeutics Inc. Stock a Short Sell?
10/13/2014 8:05:02 AM - Motley Fool


At Current Levels, Geron Has A Very Favorable Risk/Reward Profile
10/8/2014 5:08:00 PM - Seeking Alpha


The Next Industry Google Plans to Transform
9/28/2014 5:45:02 PM - Motley Fool


Following Biotech Stocks After Price Declines Of Greater Than 50%
9/25/2014 4:03:00 PM - Seeking Alpha


Geron's Imetelstat: No Threat Now Or Possibly Ever To Incyte's Jakafi Franchise
9/23/2014 1:46:00 PM - Seeking Alpha


Why Geron Corporation Stock Is Down a Shocking 52% in 2014
9/23/2014 11:20:15 AM - Motley Fool


Living Longer And Making Money: Life Extending Businesses
9/17/2014 11:09:00 AM - Seeking Alpha


Why You Shouldn't Bet Against Geron Corporation (GERN) Stock - Tale of the Tape
9/8/2014 7:58:00 AM - Zacks.com


Geron: Best Buy In The Market
9/2/2014 2:23:00 AM - Seeking Alpha